[Federal Register Volume 86, Number 190 (Tuesday, October 5, 2021)]
[Notices]
[Pages 55105-55106]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-21641]


-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Aviation Administration

[Summary Notice No. 2021-01]


Petition for Exemption; Summary of Petition Received; Merck & 
Co., Inc.

AGENCY: Federal Aviation Administration (FAA), Department of 
Transportation (DOT).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: This notice contains a summary of a petition seeking relief 
from specified requirements of Federal Aviation Regulations. The 
purpose of this notice is to improve the public's awareness of, and 
participation in, the FAA's exemption process. Neither publication of 
this notice nor the inclusion nor omission of information in the 
summary is intended to affect the legal status of the petition or its 
final disposition.

DATES: Comments on this petition must identify the petition docket 
number and must be received on or before October 25, 2021.

ADDRESSES: Send comments identified by docket number FAA-2021-0709 
using any of the following methods:
     Federal eRulemaking Portal: Go to http://www.regulations.gov and follow the online instructions for sending your 
comments electronically.
     Mail: Send comments to Docket Operations, M-30; U.S. 
Department of Transportation, 1200 New Jersey Avenue SE, Room W12-140, 
West Building Ground Floor, Washington, DC 20590-0001.
     Hand Delivery or Courier: Take comments to Docket 
Operations in Room W12-140 of the West Building Ground Floor at 1200 
New Jersey Avenue SE, Washington, DC 20590-0001, between 9 a.m. and 5 
p.m., Monday through Friday, except Federal holidays.
     Fax: Fax comments to Docket Operations at (202) 493-2251.
    Privacy: In accordance with 5 U.S.C. 553(c), DOT solicits comments 
from the public to better inform its rulemaking process. DOT posts 
these comments, without edit, including any personal information the 
commenter provides, to

[[Page 55106]]

http://www.regulations.gov, as described in the system of records 
notice (DOT/ALL-14 FDMS), which can be reviewed at http://www.dot.gov/privacy.
    Docket: Background documents or comments received may be read at 
http://www.regulations.gov at any time. Follow the online instructions 
for accessing the docket or go to the Docket Operations in Room W12-140 
of the West Building Ground Floor at 1200 New Jersey Avenue SE, 
Washington, DC 20590-0001, between 9 a.m. and 5 p.m., Monday through 
Friday, except Federal holidays.

FOR FURTHER INFORMATION CONTACT: Alphonso Pendergrass, 
alphonso.pendergrass@faa.gov, Office of Rulemaking, Federal Aviation 
Administration, 800 Independence Avenue SW, Washington, DC 20591.
    This notice is published pursuant to 14 CFR 11.85.

    Issued in Washington, DC.
Timothy R. Adams,
Acting Executive Director, Office of Rulemaking.

Petition for Exemption

    Docket No.: FAA-2021-0709.
    Petitioner: Merck & Co., Inc.
    Section(s) of 14 CFR Affected: Sec.  91.211(b)(1)(ii).
    Description of Relief Sought: Merck seeks an alternative means of 
compliance for 14 CFR 91.211(b)(1)(ii) that will permit it to fly above 
FL 410 without one pilot wearing an oxygen mask. This request is based 
on additional conditions and limitations as well as the design features 
of the Gulfstream G550/650 aircraft designed to reduce the likelihood 
of decompression and provide for an automated emergency descent in the 
event of a decompression.

[FR Doc. 2021-21641 Filed 10-4-21; 8:45 am]
BILLING CODE 4910-13-P


